News
A collection of the very latest news items relevant to the cell migration community, selected from the CMC, news@nature.com and journals from the Nature family.
α-Actinin: More than a linker.
Standfirst
A study of actinin-actin binding has revealed novel features — such as length variability and actin monofilament binding — important for the understanding of cytoskeleton dynamics.
Original research paper: α-Actinin: More than a linker. Consortium Updates, http://www.cellmigration.org/resource/cmcnews.shtml#apr07a (March 2007)
Seed money to bring in pioneers.
Standfirst
California's stem-cell initiative has finally handed out its first research grants, but researchers doubt whether all the money will actually move the field forward.
Original research paper: Seed money to bring in pioneers. Nature, http://www.nature.com/nature/journal/v446/n7133/full/446238a.html (14 March 2007)
Agencies join forces to share data.
Standfirst
The US government is considering a massive plan to store almost all scientific data generated by federal agencies in publicly accessible digital repositories.
Original research paper: Agencies join forces to share data. Nature, http://www.nature.com/nature/journal/v446/n7134/full/446354b.html (22 March 2007)
Experts call for active surveillance of drug safety.
Standfirst
Data mining of existing health-record databases as an active surveillance system could pick up early warnings of a drug's adverse side effects.
Original research paper: Experts call for active surveillance of drug safety. Nature, http://www.nature.com/nature/journal/v446/n7134/full/446358b.html (22 March 2007)
Microscopy: Tip-top imaging.
Standfirst
Images of nanoscale structures can be constructed using the flow of electrons ejected from a metal probe tip — a technique that adds a new dimension to established methods of microscopy.
Original research paper: Microscopy: Tip-top imaging. Nature, http://www.nature.com/nature/journal/v446/n7135/full/446500a.html (29 March 2007)
Trials race rashly ahead for regulatory immune cells.
Standfirst
Depletion of regulatory T cells rapidly causes massive inflammation and death, suggesting that regulatory immune cells could be an effective treatment for people with autoimmune diseases.
Original research paper: Trials race rashly ahead for regulatory immune cells. Nature Medicine, http://www.nature.com/nm/journal/v13/n3/full/nm0307-227.html (28 February 2007)
